| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |